
Medistep Healthcare
August 8, 2025 – August 12, 2025
Price | ₹43 - ₹43 |
Premium | ₹12 |
---|---|
Lot size | 3000 |
Allotment | Aug 13, 2025 |
Listing | Aug 18, 2025 |
Medistep Healthcare About
Category | Lot(s) | Qty | Amount | Reserved |
---|---|---|---|---|
INDIVIDUAL | 2 | 6000 | 258000 | 0 |
sHNI | 3 | 9000 | 387000 | 0 |
bHNI | 8 | 24000 | 1032000 | 0 |
IPO Details
Total Issue Size | 37,44,000 shares (aggregating up to 16.10 Cr) |
Fresh Issue | 37,44,000 shares (aggregating up to 16.10 Cr) |
Issue Type | Fixed Price IPO |
Listing At | NSE SME |
Share Holding Pre Issue | 1,04,65,546 shares |
Share Holding Post Issue | 1,42,09,546 shares |
Reserved for Market Maker | 1,89,000 shares |
IPO Reservation
Investor Category | Shares Offered |
---|---|
Retail Shares Offered | 50% of the Net Issue |
NII Shares Offered | 50% of the Net Issue |
Key Performance Indicators
KPI | Values |
---|---|
ROE | 44.44% |
ROCE | 59.10% |
RoNW | 44.44% |
Financial Details In Crores
Period Ended | Jun-24 | Mar-24 | Mar-23 | Mar-22 |
---|---|---|---|---|
Assets | 24.0 | 15.0 | 14.7 | 7.1 |
Total Income | 11.3 | 31.6 | 27.7 | 7.6 |
Profit After Tax | 1.0 | 2.9 | 0.9 | 0.2 |
Net Worth | 13.7 | 11.7 | 1.1 | 0.3 |
Reserves and Surplus | 3.3 | 6.8 |
Company Overview
Incorporated: June 2023
Type: Public, non-government pharmaceutical company
Key Offerings:
Sanitary Pads (feminine hygiene)
Energy Powder (supplement)
Pharmaceutical & Nutraceutical Products
Intimate Care & Hygiene Products
Surgical Products
Revenue (Annualized, FY 2024): ₹45.00 crore
Profit After Tax (PAT): ₹4.08 crore
Employees (as of Dec 28, 2024): 9 on payroll; daily-wage laborers used as needed
Focus: Quality healthcare and hygiene products with plans for product line expansion
Strength
Experienced Leadership: Promoter-led with a capable management team.
Cost Efficiency: Benefits from economies of scale in production and supply chain.
Diversified Portfolio: Mix of in-house manufacturing and trading across healthcare segments.
Weakness
Geographic Concentration: Heavy reliance on Gujarat market exposes business to regional risks.
Operational Dependency: Disruptions at the manufacturing facility may impact overall operations.
Supply Chain Risk: Dependence on domestic third-party raw material suppliers may lead to delays or shortages.
Medistep Healthcare Lead Manager(s)
Medistep Healthcare Address
05, S. No-245/B, Plot-19, T.P.S. 56,
Free Way Trade Center, Nr.A-One Hotel N.H.-8
Narol Gam, Narol Daskroi
Ahmedabad, Gujarat, 382405
Phone: +91 87808 46963
Email: Info@medistephc.com
Website: https://www.medistephc.com/